Literature DB >> 20068572

Myelodysplastic syndromes: lost between two states?

C Acquaviva, V Gelsi-Boyer, D Birnbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20068572     DOI： 10.1038/leu.2009.157

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

Review 1.  Molecular aspects of myeloproliferative neoplasms.

Authors:  François Delhommeau; Dorota Jeziorowska; Christophe Marzac; Nicole Casadevall
Journal:  Int J Hematol       Date:  2010-02-27       Impact factor: 2.490

Review 2.  Infections in myelodysplastic syndromes.

Authors:  Andréa Toma; Pierre Fenaux; François Dreyfus; Catherine Cordonnier
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

3.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.

Authors:  Myunggon Ko; Hozefa S Bandukwala; Jungeun An; Edward D Lamperti; Elizabeth C Thompson; Ryan Hastie; Angeliki Tsangaratou; Klaus Rajewsky; Sergei B Koralov; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

Review 4.  Myeloid malignancies: mutations, models and management.

Authors:  Anne Murati; Mandy Brecqueville; Raynier Devillier; Marie-Joelle Mozziconacci; Véronique Gelsi-Boyer; Daniel Birnbaum
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

5.  Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Julien Rocquain; Nadine Carbuccia; Virginie Trouplin; Stéphane Raynaud; Anne Murati; Meyer Nezri; Zoulika Tadrist; Sylviane Olschwang; Norbert Vey; Daniel Birnbaum; Véronique Gelsi-Boyer; Marie-Joelle Mozziconacci
Journal:  BMC Cancer       Date:  2010-08-02       Impact factor: 4.638

6.  NAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes.

Authors:  Archita Das; Neekkan Dey; Arunava Ghosh; Tanusree Das; Indu B Chatterjee
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

7.  Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.

Authors:  M J Walter; L Ding; D Shen; J Shao; M Grillot; M McLellan; R Fulton; H Schmidt; J Kalicki-Veizer; M O'Laughlin; C Kandoth; J Baty; P Westervelt; J F DiPersio; E R Mardis; R K Wilson; T J Ley; T A Graubert
Journal:  Leukemia       Date:  2011-03-18       Impact factor: 11.528

8.  Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms.

Authors:  M Brecqueville; N Cervera; J Adélaïde; J Rey; N Carbuccia; M Chaffanet; M J Mozziconacci; N Vey; D Birnbaum; V Gelsi-Boyer; A Murati
Journal:  Blood Cancer J       Date:  2011-08-26       Impact factor: 11.037

9.  Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.

Authors:  T-C Chen; H-A Hou; W-C Chou; J-L Tang; Y-Y Kuo; C-Y Chen; M-H Tseng; C-F Huang; Y-J Lai; Y-C Chiang; F-Y Lee; M-C Liu; C-W Liu; C-Y Liu; M Yao; S-Y Huang; B-S Ko; S-C Hsu; S-J Wu; W Tsay; Y-C Chen; H-F Tien
Journal:  Blood Cancer J       Date:  2014-01-17       Impact factor: 11.037

Review 10.  Realgar (α-As4S4) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.

Authors:  Miao Zhang; Jia-Yi Zhang; Ming-Qian Sun; Peng Lu; Jian-Xun Liu
Journal:  Chin J Integr Med       Date:  2020-05-16       Impact factor: 1.978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.